Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for the front and back of the eye, today announced that Ben Bergo, Co-Founder and Chief Executive Officer, TD Cowen, 43 Will participate in th Annual Healthcare Conference. March 6-8, 2023 in Boston. Mr. Burgo will also be available for one-on-one meetings … Read more